Related Experiment Videos
Clinical perspectives in primary nocturnal enuresis
G A Gimpel1, W J Warzak, B R Kuhn
1Utah State University, Logan, USA.
Clinical Pediatrics
|February 25, 1998
Summary
Primary nocturnal enuresis (PNE) treatment options are reviewed. Enuresis alarms are recommended for families able to adhere to protocols, while desmopressin offers a safe, fast-acting alternative for pediatric bedwetting.
Area of Science:
- Pediatric Urology
- Sleep Medicine
- Behavioral Pediatrics
Background:
- Primary nocturnal enuresis (PNE) is a common pediatric condition.
- Awareness of current research on PNE etiology and treatment varies among professionals.
Purpose of the Study:
- To provide a comprehensive overview of PNE, focusing on etiology, evaluation, and treatment.
- To discuss the most current PNE treatments and their recent research findings.
Main Methods:
- Literature review of PNE etiology and evaluation.
- Analysis of current treatment options: imipramine, desmopressin acetate arginine vasopressin, and enuresis alarms.
- Evaluation of recent research on treatment effectiveness, long-term efficacy, cost, and safety.
Main Results:
- Enuresis alarms are identified as the treatment of choice for compliant families due to long-term efficacy, cost, and safety.
- Desmopressin acetate arginine vasopressin is a safe alternative with rapid response and ease of administration.
Conclusions:
- Treatment selection for PNE should consider family capability, desired response time, and administration ease.
- Enuresis alarms and desmopressin represent effective, evidence-based options for managing pediatric primary nocturnal enuresis.